Hyperbaric oxygen and cancer: more complex than we expected Liu WenwuSun XuejunLiu Kan Editorial 24 January 2013 Pages: 79 - 81
Role of targeted agents in metastatic colorectal cancer Hans PrenenLoredana VecchioneEric Van Cutsem Review 05 May 2013 Pages: 83 - 96
Tumours and tissues: similar homeostatic systems? Romano Demicheli Review 02 May 2013 Pages: 97 - 105
Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis Gaofeng PanShaobo KeJinping Zhao Review 21 March 2013 Pages: 107 - 116
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept Nicole ShonkaYuji PiaoJohn de Groot Original Research 24 January 2013 Pages: 117 - 125
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer Melanie Poulin-CostelloLaurent AzoulayMichael Wolf Original Research Open access 27 April 2013 Pages: 127 - 136
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06 C. VillanuevaG. RomieuXavier Pivot Original Research 23 April 2013 Pages: 137 - 143
Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer Shinichi OtaJean-Francois H. GeschwindShanmugasundaram Ganapathy-Kanniappan Original Research 26 March 2013 Pages: 145 - 151
Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma Anna J. LomaxCostas K. YannakouMark A. Rosenthal Day-to-Day Practice 21 February 2013 Pages: 153 - 155